The NSW Government has committed $9 million towards clinical trials to evaluate the safety and effectiveness of cannabis medicine in providing relief from the symptoms of serious conditions.
Three clinical trials are currently underway investigating the potential of cannabis medicine to:
- Reduce seizures in children with severe treatment-resistant epilepsy, through a partnership with the Sydney Children’s Hospitals Network
- Improve appetite and appetite-related symptoms in adult palliative care patients with advanced cancer
- Prevent chemotherapy-induced nausea and vomiting in adult patients where standard treatments have proven ineffective.
There are a number of other clinical trials underway across Australia exploring new and improved treatments, devices and products. These clinical trials, including trials of cannabis medicines, must be registered on the Australian New Zealand Clinical Trials Registry (ANZCTR). You can search for relevant clinical trials on the ANZCTR website, which can be found here.
Information about clinical trials underway internationally can be found at:
Children with severe, treatment-resistant epilepsy, through a partnership with the Sydney Children’s Hospitals Network.
Adults with chemotherapy-induced nausea and vomiting, where standard treatment is ineffective.
Adult palliative care patients, focusing on quality of life, particularly appetite and appetite-related symptoms